You are here

Multiplexed Ovarian Cancer Microfluidic Tissue Microarray

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43CA177146-01A1
Agency Tracking Number: R43CA177146
Amount: $225,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: PA13-088
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
4909 Brown Villa Cove, Salt Lake City, UT, 84123-4436
DUNS: 171205177
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 BENJAMIN BROOKS
 (801) 885-4073
 bbrooks@microfl.com
Business Contact
 BENJAMIN BROOKS
Phone: (801) 885-4073
Email: bbrooks@microfl.com
Research Institution
 Stub
Abstract
Project Summary We propose an instrument system for automated, multiplexed cell- and tissue-based experiments (i.e. tissue microarrays) called the Microfluidic Flow Cell Array (MFCA). The MFCA consists of a microfluidic flow cell array integrated with an inverted fluorescent microscope, allowing the observation of 48 flow chambers simultaneously or an individual chamber at higher magnification. The proposed instrument will be used to novel cell- and tissue-based assays in a highly parallel manner that are otherwise difficult to perform. Our goal is to build a platform for producing a tissue microarray that maintains many of the characteristics found in cells in vivo and allows for the investigation of cell-surface, cell-cell, and especially tumor-stroma interactions, cell toxicity studies, and tissue toxicity studies in a multiplexed fashion. As a Phase I application, this proposal's focus is ovarian cancer tissue slice toxicity testing to determine the optimal chemotherapeutic agents for a specific patient

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government